Info

About Morphochem AG (www.morphochem.de): Morphochem was founded in 1998 and currently employs 45 staff in Munich, Germany and Basel, Switzerland. It has developed a unique and highly integrated chemical genomics drug discovery platform that it is applying to the development of a pipeline of drugs for unmet medical needs in major areas of indications such as thrombosis and infectious diseases as well as partnering its technology with others. Morphochem has raised €84.7 million from a world class syndicate of investors including Techno Venture Management (TVM), Alta Berkeley, Alta California, Life Science Partners, Merlin Biosciences, Nomura International, West LB Panmure, 3i Bioscience Investment Trust, 3i Group, Domain Associates, Mayfield Fund, Viscardi, IKB Venture Capital, Süd VC, KB Lux, Bank Julius Bär, Bionex Investments, and others including federal and state government sources.